Global Triptorelin Acetate Market Insights, Forecast to 2025
Triptorelin Acetate is a peptide formulation for injection that was initially developed and continues to be used mainly in the treatment of advanced metastatic prostate cancer. Additional indications developed subsequently include the treatment of uterine fibroids (a benign tumour of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilisation).
The global production of triptorelin acetate is about 2770 k units in 2015, the production region is mainly concentrated in Europe, the biggest three countries are France, Germany and Ireland. The top two companies are Ipsen and Ferring, they occupies about 95% market shares;
Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption Europe is about 38%, the North America consumes about 12% market share, China occupies about 9% market share, Japan occupies about 8.29% market share.
The production and consumption region is different, the production region is mainly concentrated in Europe, the consumption region is dispersion in all over the world; the countries which do not include in the Europe mainly depends on import.
The global Triptorelin Acetate market is valued at 460 million US$ in 2018 and will reach 620 million US$ by the end of 2025, growing at a CAGR of 3.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Triptorelin Acetate market based on company, product type, end user and key regions.
This report studies the global market size of Triptorelin Acetate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Triptorelin Acetate in these regions.
This research report categorizes the global Triptorelin Acetate market by top players/brands, region, type and end user. This report also studies the global Triptorelin Acetate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Ipsen
Ferring
Chengdu Tiantaishan
TECNOFARMA
Changchun Gensci
Market size by Product
0.1 mg
3 mg
11.25 mg
Market size by End User
Male Disease
Female Disease
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Triptorelin Acetate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Triptorelin Acetate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Triptorelin Acetate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Triptorelin Acetate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Triptorelin Acetate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Triptorelin Acetate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The global production of triptorelin acetate is about 2770 k units in 2015, the production region is mainly concentrated in Europe, the biggest three countries are France, Germany and Ireland. The top two companies are Ipsen and Ferring, they occupies about 95% market shares;
Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption Europe is about 38%, the North America consumes about 12% market share, China occupies about 9% market share, Japan occupies about 8.29% market share.
The production and consumption region is different, the production region is mainly concentrated in Europe, the consumption region is dispersion in all over the world; the countries which do not include in the Europe mainly depends on import.
The global Triptorelin Acetate market is valued at 460 million US$ in 2018 and will reach 620 million US$ by the end of 2025, growing at a CAGR of 3.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Triptorelin Acetate market based on company, product type, end user and key regions.
This report studies the global market size of Triptorelin Acetate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Triptorelin Acetate in these regions.
This research report categorizes the global Triptorelin Acetate market by top players/brands, region, type and end user. This report also studies the global Triptorelin Acetate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Ipsen
Ferring
Chengdu Tiantaishan
TECNOFARMA
Changchun Gensci
Market size by Product
0.1 mg
3 mg
11.25 mg
Market size by End User
Male Disease
Female Disease
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Triptorelin Acetate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Triptorelin Acetate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Triptorelin Acetate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Triptorelin Acetate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Triptorelin Acetate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Triptorelin Acetate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
